Johnson & Johnson
Johnson & Johnson price
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
- Stock ticker
- JNJ
- Company
- Johnson & Johnson
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- 12
- Launch date
- Jan 2, 1962
- Listed exchange
- NYSE
Financials
Summary: JNJ reported Revenue of 25.31B (+6.60%), beating expectations; EPS of 2.90 (+4.69%), beating expectations.
Dividends
Johnson & Johnson conversion tables
 |  |
|---|---|
| 0.5 JNJ | 128.05 USD |
| 1 JNJ | 256.1 USD |
| 5 JNJ | 1,280.5 USD |
| 10 JNJ | 2,561 USD |
| |
|---|---|
| 0.5 USD | 0.0019524 JNJ |
| 1 USD | 0.0039047 JNJ |
| 5 USD | 0.019524 JNJ |
| 10 USD | 0.039047 JNJ |
More to explore
FAQ
JNJ is trading at $256.10, -0.99% over the last 24 hours. Track live moves on the price chart at the top of this page.
The JNJ stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. JNJ is currently trading at $256.10, -0.99% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on JNJ price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. JNJ's P/E ratio is currently 29.79 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from JNJ; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against JNJ's historical range and other companies in the Healthcare sector.
Johnson & Johnson's market cap is currently 619.55B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.